We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04385290
Brief Title: Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC) (MOSAIC)

First Submitted : May 8, 2020
First Submitted that Met QC Criteria : May 8, 2020
First Posted : May 12, 2020

Last Update Submitted that Met QC Criteria : November 28, 2022
Last Update Posted : December 1, 2022